FSTL1 and obstructive sleep apnea syndrome: We quantified baseline circulating FSTL1 levels in all participants and detected a significant decline in FSTL1 levels (10361.74 ± 177.04, p < 0.001) in people with OSA compared to CTRL participants (11675.72 ± 393.20; Table 1).